SDC1 and lung carcinoma: Studies have pinpointed soluble SDC-1 ectodomain in the serum of lung cancer patients (59), Hodgkin’s lymphoma patients (49), and myeloma patients as well as within the ECM of the myeloma microenvironment (40, 41).